Last reviewed · How we verify
Advanced or metastatic urothelial carcinoma
Approved treatments
- Azd5363 · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Advanced or metastatic urothelial carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Advanced or metastatic urothelial carcinoma treatment landscape brief
- Advanced or metastatic urothelial carcinoma treatment updates RSS
Frequently asked questions about Advanced or metastatic urothelial carcinoma
What drugs treat Advanced or metastatic urothelial carcinoma?
Tracked treatments include Azd5363.
What is the treatment for Advanced or metastatic urothelial carcinoma?
Standard treatment for Advanced or metastatic urothelial carcinoma includes Azd5363. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Advanced or metastatic urothelial carcinoma patent cliff · Advanced or metastatic urothelial carcinoma CI report
- Treatment: Azd5363 · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing